University of Michigan, 2800 Plymouth Rd, Bldg 16, Floor 4, 016-400S-25, Ann Arbor, MI 48109-2800. Email:
Am J Manag Care. 2021 Sep;27(9):364-365. doi: 10.37765/ajmc.2021.88671.
As awareness of nonalcoholic fatty liver disease (NAFLD) rises, it is essential to develop and implement a rigorously determined approach to identify patients who will, or will not, benefit from diagnostic evaluation.
随着人们对非酒精性脂肪性肝病(NAFLD)认识的提高,制定并实施一种严格确定的方法来识别哪些患者将从诊断评估中获益或不会获益至关重要。